COPS5 and esophageal squamous cell carcinoma: The log‐rank test indicated that ESCC patients with JAB1 overexpression had a markedly lower five‐year survival rate compared to the low‐expression group (27.7% vs. 54.2%, P = 0.001, Fig 1d, Table 2).